Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2016 · 10-Q
Revenue$112.38M$112.38M+3.6% vs Q1 2015 Net Income$22.71M$22.71M−5.0% vs Q1 2015 EPS Diluted$0.61$0.61−4.7% vs Q1 2015 Gross Profit$75,391,000+3.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$31,833,000−10.9% Free Cash Flowderived$25,712,000−16.6% Margins · derivedGross margin67.1%−0.3 pt vs Q1 2015
Operating margin27.6%−4.9 pt vs Q1 2015
Net margin20.2%−1.8 pt vs Q1 2015
ended Sep 30, 2015 · filed Nov 9, 2015 · 40 d after period end